The Patent Finder
US

Crystalline (2S,4R)-5-(5'-Chloro-2'-Fluoro-[1,1'-Biphenyl]-4-YL)-2-(ETHOXYMETHYL)-4-(3-Hydroxyisoxazole-5-Carboxamido)-2-Methylpentanoic Acid and Uses Thereof

US 11,230,536 In force
OverviewFamilyAssignmentsSources & methods

Term ends Mar 7, 2037 · Medium confidence

Why Medium: A parent in the chain could not be resolved.

Held by Eonhf, Inc.
Filed Jul 14, 2020 as application 16/928,206 · Granted Jan 25, 2022
Base term, 20 years from filing
Today
20 years from filing
2017 2037
Clock starts
Mar 7, 2017
Term ends
Mar 7, 2037
Granted
Jan 25, 2022
base term fee events Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
None
Terminal disclaimer
No disclaimer on this record.
1 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
7
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.

This patent's term is its 20-year base term, with no adjustment for prosecution delay. 1 of 3 maintenance fees is paid so far. Confidence: Medium. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Mar 7, 2017, when application 15/452,333, the earliest non-provisional in its chain, was filed (this one was filed Jul 14, 2020); a parent in its chain could not be resolved (the next row)Mar 7, 2037High confidence
Continuity chainA parent in the chain could not be resolveddated from this application's own claimMedium confidence
Patent term adjustmentNone on fileno changeHigh confidence
Terminal disclaimer capNone on recordno cap appliedHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events1 of 3 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderMar 7, 2037Medium confidence

This family

US 10,100,021Lapsed on the fee record
Oct 2026
Oct 2026
US 10,472,335In force
Mar 2037
Mar 2037
US 10,752,599In force
Mar 2037
Mar 2037
US 11,230,536this patent
Mar 2037
Mar 2037
US 11,718,591In force
Mar 2037
Mar 2037
Application 18/209,871Abandoned
not computed
not computed
US 12,351,561In force
Mar 2037
Mar 2037
The applications whose file history this site holds. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Apr 28, 2026
Reel 75494, frame 756
Theravance Biopharma R&D IP, LLCEonhf, Inc.Assignment of Assignor's Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited